Clinical Trials Browser

Recurrence, Triple Negative Breast Neoplasms

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Recurrence, Lymphoma, Large B-Cell, Diffuse

Head and Neck Neoplasms, Recurrence

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Neoplasm Metastasis, Recurrence

Recurrence, Lymphoma, Large B-Cell, Diffuse

Nasopharyngeal Carcinoma, Recurrence

Recurrence, Lymphoma, Large-Cell, Anaplastic

Recurrence, Leukemia, Myeloid, Acute

Recurrence, Lymphoma, Large B-Cell, Diffuse

Glioblastoma, Recurrence

Leukemia, Lymphoma, Recurrence, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Extranodal Extension, Recurrence, Lymphoma, Large B-Cell, Diffuse

Recurrence, Leukemia, Myeloid, Acute

Recurrence, Lymphoma, Large B-Cell, Diffuse, Dendritic Cell Sarcoma, Interdigitating

Carcinoma, Ovarian Epithelial, Recurrence

Recurrence, Lymphoma, T-Cell, Peripheral

Lymphoma, Recurrence

Lymphoma, Follicular, Recurrence

Carcinoma, Hepatocellular, Recurrence

Hodgkin Disease, Recurrence

Recurrence, Lymphoma, B-Cell

Lymphoma, Recurrence

Lymphoma, Non-Hodgkin, Recurrence

Recurrence, Lymphoma, B-Cell

Nasopharyngeal Carcinoma, Recurrence

Uterine Cervical Neoplasms, Recurrence

Hodgkin Disease, Recurrence

Recurrence, Lymphoma, T-Cell, Peripheral

Recurrence, Lymphoma, Large B-Cell, Diffuse

Recurrence, Small Cell Lung Carcinoma

Esophageal Squamous Cell Carcinoma, Neoplasm Metastasis, Recurrence

Head and Neck Neoplasms, Recurrence

Recurrence, Lymphoma, Large B-Cell, Diffuse

Neoplasms, Recurrence, Lymphoma, Large B-Cell, Diffuse

Lymphoma, Non-Hodgkin, Recurrence

Hodgkin Disease, Recurrence

Neoplasm Metastasis, Recurrence

Graft vs Host Disease, Recurrence

Multiple Myeloma, Recurrence, Disease Progression

Nasopharyngeal Carcinoma, Recurrence

Breast Neoplasms, Recurrence

Multiple Myeloma, Recurrence

Adenocarcinoma, Recurrence

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms, Neoplasm Metastasis, Recurrence

Recurrence, Neoplasms, Plasma Cell

Recurrence, Lymphoma, T-Cell, Peripheral

Burkitt Lymphoma, Recurrence, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma

Ovarian Neoplasms, Recurrence

Recurrence, Endometrial Neoplasms

Clinical Trials

BELLA

CD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Non-Hodgkins Lymphoma

Safety and Superiority of Penicillamine in Radiosensitization of Recurrent Head and Neck Cancer

V-CHANCE

Study of BEBT-908 in the Relapsed or Refractory Diffuse Large B-cell Lymphoma Subjects

Tranilast as a Radiosensitizer in Reradiation of Nasopharyngeal Carcinoma

CRU3

Study of Selinexor Combined With Chidamide in Relapsed/Refractory Acute Leukemia (AML) Patients

Prospective Clinical Study of ZPR Regimen in Relapsed/Refractory Diffuse Large B-cell Lymphoma

TaRRGET

Venetoclax Plus IM2 Regimen for Relapsed and Refractory T Lymphoblastic Lymphoma/Leukemia

Decitabine and Anti-PD-1 in R/R DLBCL

Phase 2, Open-Label, Single Arm Study, With BST-236 in Adults With R/R AML or Higher-Risk MDS

Relyage

BOLD

A Single-arm, Multicenter, Prospective Clinical Study of Mitoxantrone Liposome Combined With Chidamide and Azacitidine in the Treatment of Relapsed and Refractory Peripheral T-cell Lymphoma

Camrelizumab Combined With CD30 CAR-T in the Treatment of Relapsed/Refractory CD30+ Lymphoma

Orelabrutinib Plus Rituximab Followed by Maintenance With Orelabrutinib for Relapsed and Refractory Follicular Lymphoma(RR FL)

A Study to Evaluate TACE Sequential Tislelizumab as Adjuvant Therapy in Participants With HCC at High Risk of Recurrence After Curative Resection

PD-1 Inhibitor Combined With Decitabine Followed by ASCT as Second-line Therapy for Relapsed or Refractory Classic Hodgkin's Lymphoma

SHR1459 in Combination With YY-20394 in Recurrent and Refractory B-cell Non-Hodgkin's Lymphoma

Ibrutinib Combined With Rituximab for Treatment of Relapsed Refractory MYD88 and CD79A/B (or CD79B Alone) DLBCL Who Have Received at Least Two Prior Therapies

A Study of CD19/22 CART Cells Combined With PD-1 Inhibitor in Relapsed/Refractory B-cell Lymphoma

Study of Chidamide as a Single-agent Treatment for Patients With Relapse or Refractory B-NHL

Endostar for Locally Recurrent Nasopharyngeal Carcinoma

A Study of TQB2450 Injection in Subjects With PD-L1 Positive Recurrent or Metastatic Cervical Cancer

BASALT

Chidamide Combination With Lenalidomide in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma

Chidamide Combined With VDDT Regimen in the Relapse and Refractory Diffuse Large B Cell Lymphoma

Irinotecan Plus Lobaplatin Versus Irinotecan in the Second-line Treatment of Small Cell Lung Cancer

Apatinib in the Treatment of Recurrence or Metastasis of Esophageal Cancer

RePASS

LEGEND

Study of Ibrutinib in Combination With Bendamustine and Rituximab for Patients With Relapsed/Refractory Aggressive BCL

CAR-T for R/R B-NHL

SHR-1210 Alone or in Combination With Decitabine in Relapsed or Refractory Hodgkin Lymphoma

MICADO

A Trial to Evaluate the Efficacy of Poziotinib, Pan HER Inhibitor in Recurrent/Metastatic Esophageal Cancer (R/M ESCC)

Prophylactic Donor Lymphocyte Infusion After Allo-PBSCT for Patients With Very High-risk Hematologic Malignancies

MM-POM-2018

Nimotuzumab for Recurrent Nasopharyngeal Carcinoma

A Phase II Study of Irinotecan in 3 Line or More Therapy in Local Recurrence or Metastatic Breast Cancer

CARFI

A Study of Anlotinib in Recurrent/Metastatic Head and Neck Adenocarcinomas

DOSE

Daratumumab, Thalidomide and Dexamethasone in Relapse and/or Refractory Myeloma

Chidamide Combined With PECM in Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)

MB-CART19.1 in Patients With R/R ALL

Apatinib Plus Etoposide Versus Etoposide Alone for Platinum-resistant Recurrent Ovarian Cancer

Virexxa (Sodium Cridanimod) w/Progestin Therapy in Pts w/Progesterone Receptor Neg Recurrent/Persistent Endometrial CA